TR199901101T2 - Gastroenstentinal hastal�klar�n tedavisine y�nelik bizmut ve nsaid i�eren bile�imler. - Google Patents

Gastroenstentinal hastal�klar�n tedavisine y�nelik bizmut ve nsaid i�eren bile�imler.

Info

Publication number
TR199901101T2
TR199901101T2 TR1999/01101T TR9901101T TR199901101T2 TR 199901101 T2 TR199901101 T2 TR 199901101T2 TR 1999/01101 T TR1999/01101 T TR 1999/01101T TR 9901101 T TR9901101 T TR 9901101T TR 199901101 T2 TR199901101 T2 TR 199901101T2
Authority
TR
Turkey
Prior art keywords
treatment
nsaid
compositions containing
gastrointestinal diseases
containing bismuth
Prior art date
Application number
TR1999/01101T
Other languages
English (en)
Turkish (tr)
Inventor
Davidson Kaunitz Jonathan
Rickford Carryl Owen
Tanaka Shin
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Publication of TR199901101T2 publication Critical patent/TR199901101T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TR1999/01101T 1996-11-22 1997-11-21 Gastroenstentinal hastal�klar�n tedavisine y�nelik bizmut ve nsaid i�eren bile�imler. TR199901101T2 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75551796A 1996-11-22 1996-11-22

Publications (1)

Publication Number Publication Date
TR199901101T2 true TR199901101T2 (xx) 1999-07-21

Family

ID=25039481

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/01101T TR199901101T2 (xx) 1996-11-22 1997-11-21 Gastroenstentinal hastal�klar�n tedavisine y�nelik bizmut ve nsaid i�eren bile�imler.

Country Status (7)

Country Link
EP (1) EP0941102A1 (fr)
CN (1) CN1238694A (fr)
CA (1) CA2271381A1 (fr)
HU (1) HUP9904073A3 (fr)
NO (1) NO992468L (fr)
TR (1) TR199901101T2 (fr)
WO (1) WO1998022118A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
EP1154771A4 (fr) * 1999-02-26 2005-04-20 Nitromed Inc Inhibiteurs de la pompe a proton nitroses et nitrosyles, compositions et procedes d'utilisation
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
TWI289557B (en) 1999-06-17 2007-11-11 Takeda Chemical Industries Ltd A crystal of a hydrate of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
DK1337525T3 (da) * 2000-12-01 2011-09-19 Takeda Pharmaceutical Fremgangsmåde til krystallisering af (R)- eller (S)-lansoprazol
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US6514960B1 (en) * 2001-08-27 2003-02-04 Hedonist Biochemical Technologies Co., Ltd. Use of bismuth subgallate in inhibition of production of nitric oxide synthase
WO2004012659A2 (fr) 2002-08-01 2004-02-12 Nitromed, Inc. Inhibiteurs nitroses de la pompe a protons, compositions et procedes d'utilisation
EP1552833B1 (fr) 2002-10-16 2016-12-28 Takeda Pharmaceutical Company Limited Procédé de préparation d'un iosmère optiquement actif du lansoprazole
AU2005264864B2 (en) 2004-06-16 2011-08-11 Takeda Pharmaceutical Company Limited Multiple PPI dosage form
KR101148399B1 (ko) * 2005-06-22 2012-05-23 일양약품주식회사 항궤양제 및 점막보호제를 함유하는 경구용 위장질환치료용 약제 조성물
BRPI0909651A2 (pt) 2008-03-10 2015-09-22 Takeda Pharmaceutical cristal, agente farmacêutico, método para tratar ou evitar doença, uso do cristal, e, método para a produção de um cristal
JP2012502015A (ja) 2008-09-09 2012-01-26 アストラゼネカ・アクチエボラーグ 必要がある患者に医薬組成物を送達するための方法
MX2011013467A (es) 2009-06-25 2012-02-13 Astrazeneca Ab Metodo para tratar un paciente que corre el riesgo de desarollar una ulcera asociada a antiinflamatorio no esteroide (aine).
MX2014007935A (es) 2011-12-28 2014-11-14 Pozen Inc Composiciones y metodos mejorados para el suministro de omeprazol y de acido acetilsalicilico.
WO2023143573A1 (fr) * 2022-01-30 2023-08-03 上海石趣医药科技有限公司 Utilisation d'un composé contenant du bismuth dans un traitement de maladies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI910088A (fi) * 1990-01-09 1991-07-10 Gist Brocades Nv Oral farmaceutisk komposition.
US5128140A (en) * 1991-01-14 1992-07-07 The Procter & Gamble Company Swallowable pharmaceutical compositions
EP0681476B1 (fr) * 1991-11-22 1997-08-27 The Procter & Gamble Company Preparation pharmaceutique de doses unitaires de subsalicylate de bismuth
EP0550083B1 (fr) * 1991-12-06 1999-03-24 Glaxo Group Limited Médicaments pour le traitement de conditions inflammatoires ou pour l'analgésie contenants un NSAID et du citrate de bismuth-ranitidine

Also Published As

Publication number Publication date
WO1998022118A1 (fr) 1998-05-28
HUP9904073A3 (en) 2000-04-28
NO992468D0 (no) 1999-05-21
EP0941102A1 (fr) 1999-09-15
CN1238694A (zh) 1999-12-15
NO992468L (no) 1999-07-01
CA2271381A1 (fr) 1998-05-28
HUP9904073A2 (hu) 2000-03-28

Similar Documents

Publication Publication Date Title
TR199901101T2 (xx) Gastroenstentinal hastal�klar�n tedavisine y�nelik bizmut ve nsaid i�eren bile�imler.
DE69604653T2 (de) Taxol derivate, deren herstellung und diese enthaltende pharmazeutischen zusammenstellungen
DE68912237D1 (de) Dampfsensitive Zusammensetzung sowie diese enthaltende sterilisierungsanzeigende Zusammensetzung.
DK0862424T3 (da) Farmaceutiske præparater omfattende flurbiprofen
IS1947B (is) Setin bensýlamínópíperidín efnasambönd og lyfjablöndur þeirra
NO20016198L (no) Orale farmasöytiske sammensetninger som inneholder taxaner og fremgangsmåter for anvendelse av samme i behandling
BR9914044A (pt) ésteres tetrahidropirido
DK0705100T3 (da) Terapeutiske substituerede guanidiner
IT1212778B (it) Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
SE9201628D0 (sv) Pharmaceutical composition
NO972391D0 (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
ES2188582T3 (es) El uso de ranitidina-citrato de bismuto en combinacion con claritromicina o claritromicina y tetraciclina en la fabricacion de un medicamento para tratar trastornos gastrointestinales.
DE3579730D1 (de) Eisen-3-hydroxypyron- oder 3-hydroxypyridon-komplexe und diese enthaltende pharmazeutische zusammensetzungen.
NO992469L (no) Sammensetninger inneholdende vismut og NSAID samt ett eller fler anti-mikrobielle midler til behandling av gastrointestinale lidelser
EE9800400A (et) Diklofenaaki sisaldavad farmatseutilised kompositsioonid
BR9806083A (pt) Composi-Æo farmac-utica para o tratamento da hapattite c
NO993784L (no) Farmasöytiske blandinger inneholdende ibuprofen og domperidon for behandling av migrene
DE69831737D1 (de) Neurotrypsin
FI923751A0 (fi) Hexahydrobenso/f/kinolinoner.
ATE232738T1 (de) Kolostrum enthaltende pharmazeutische zusammensetzungen und deren verwendung
FR2701709B1 (fr) Forme purifiée de streptograminés, sa préparation et les compositions pharmaceutiques qui la contiennent.
ITRM930487A0 (it) Metodo e dispostivo di guida del tipo fortemente rigido per materiali d'acciaio da laminare.
TR199801021T2 (xx) Mide-ba��rsak bozukluklar�n�n �nlenmesi ve tedavisi i�in bizmut i�eren bile�imler.
IT1288708B1 (it) Composizione farmaceutica comprendente trometamina per il trattamento per via topica dell'acne vulgaris.
FR2691360B1 (fr) Compositions pharmaceutiques destinees en particulier au traitement des poches parondontales et procede de fabrication.